2025 annual financial data
Generate Biomedicines 2025 Operating margin
Generate Biomedicines 2025 operating margin with verified reported values.
Direct answer
Operating margin was -737.04%.
Operating income was -235,065,000 USD and net income was -203,154,000 USD.
Operating cash flow was -200,619,000 USD.
Get free Generate Biomedicines email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 31,893,000 USD
- Operating income
- -235,065,000 USD
- Net income
- -203,154,000 USD
- Operating cash flow
- -200,619,000 USD